These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12722341)

  • 41. Discreplasminin, a plasmin inhibitor isolated from Tityus discrepans scorpion venom.
    Brazón J; D'Suze G; D'Errico ML; Arocha-Piñango CL; Guerrero B
    Arch Toxicol; 2009 Jul; 83(7):669-78. PubMed ID: 19015833
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular cloning and functional expression of rabbit alpha2-antiplasmin.
    Jobse BN; Sutherland JS; Vaz D; Bhakta V; Sheffield WP
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):283-91. PubMed ID: 16651871
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of plasminogen by Streptococcus mutans.
    Jones MN; Holt RG
    Biochem Biophys Res Commun; 2004 Sep; 322(1):37-41. PubMed ID: 15313170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The biological role of fibrinolysis.
    Davidson JF; Walker ID
    Adv Exp Med Biol; 1984; 164():229-34. PubMed ID: 6538057
    [No Abstract]   [Full Text] [Related]  

  • 45. Serum amyloid A enhances plasminogen activation: implication for a role in colon cancer.
    Michaeli A; Finci-Yeheskel Z; Dishon S; Linke RP; Levin M; Urieli-Shoval S
    Biochem Biophys Res Commun; 2008 Apr; 368(2):368-73. PubMed ID: 18237545
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of fibrinolysis - recent developments.
    Collen D
    Prog Clin Biol Res; 1981; 72():221-8. PubMed ID: 6461014
    [No Abstract]   [Full Text] [Related]  

  • 47. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
    Doolittle RF; Pandi L
    Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasminogen assay by means of the lysis time method.
    Berg W; Korsan-Bengtsen K; Ygge J
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):127-44. PubMed ID: 16955971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular genetics of alpha 2 plasmin inhibitor.
    Aoki N
    Adv Exp Med Biol; 1990; 281():195-200. PubMed ID: 2102612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bleeding and thrombotic problems in a patient with alpha2 plasmin inhibitor deficiency.
    Hayward CP; Cinà CS; Staunton M; Jurriaans E
    J Thromb Haemost; 2005 Feb; 3(2):399-401. PubMed ID: 15670058
    [No Abstract]   [Full Text] [Related]  

  • 51. Binding of plasminogen activators to fibrin: characterization and pharmacological consequences.
    Fears R
    Biochem J; 1989 Jul; 261(2):313-24. PubMed ID: 2673218
    [No Abstract]   [Full Text] [Related]  

  • 52. Why alpha-antiplasmin must be converted to a derivative form for optimal function.
    Lee KN; Jackson KW; Christiansen VJ; Lee CS; Chun JG; McKee PA
    J Thromb Haemost; 2007 Oct; 5(10):2095-104. PubMed ID: 17883704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A rare cause of bleeding in two Indian families with congenital alpha-2-antiplasmin deficiency.
    Prabhudesai A; Shetty S; Shanmukhaiah C; Kalantri S; Bhattacharyya M; Kulkarni B
    Haemophilia; 2019 Nov; 25(6):e370-e372. PubMed ID: 31577375
    [No Abstract]   [Full Text] [Related]  

  • 54. Thrombolytic activity of BB-10153, a thrombin-activatable plasminogen.
    Comer MB; Cackett KS; Gladwell S; Wood LM; Dawson KM
    J Thromb Haemost; 2005 Jan; 3(1):146-53. PubMed ID: 15634278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The relative kinetics of clotting and lysis provide a biochemical rationale for the correlation between elevated fibrinogen and cardiovascular disease.
    Kim PY; Stewart RJ; Lipson SM; Nesheim ME
    J Thromb Haemost; 2007 Jun; 5(6):1250-6. PubMed ID: 17266698
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of homocysteine on fibrin network lysis.
    Lauricella AM; Quintana I; Castañon M; Sassetti B; Kordich L
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):181-6. PubMed ID: 16575255
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deficiency of alpha2-antiplasmin does not affect murine adipose tissue development.
    Lijnen HR
    J Thromb Haemost; 2007 Feb; 5(2):420-1. PubMed ID: 17269938
    [No Abstract]   [Full Text] [Related]  

  • 58. C1-inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis.
    Pannell R; Kung W; Gurewich V
    J Thromb Haemost; 2007 May; 5(5):1047-54. PubMed ID: 17459007
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasminogen and plasmin activity in patients with coronary artery disease.
    Drinane MC; Sherman JA; Hall AE; Simons M; Mulligan-Kehoe MJ
    J Thromb Haemost; 2006 Jun; 4(6):1288-95. PubMed ID: 16706973
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alpha2-antiplasmin is involved in the production of transforming growth factor beta1 and fibrosis.
    Kanno Y; Kuroki A; Okada K; Tomogane K; Ueshima S; Matsuo O; Matsuno H
    J Thromb Haemost; 2007 Nov; 5(11):2266-73. PubMed ID: 17958745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.